Preliminary observation of hepatic arterial chemoembolization combined with arsenic trioxide injection in treatment of primary liver cancer
10.3969/j.issn.1006-5725.2018.02.023
- VernacularTitle:肝动脉化疗栓塞联合灌注三氧化二砷治疗原发性肝癌
- Author:
Junsong JI
1
;
Ting CHEN
;
Hui WANG
;
Chenyi WANG
;
Hao YIN
;
Zhiren FU
Author Information
1. 上海长征医院闸北分院肝移植科 上海200070
- Keywords:
hepatic arterial chemoembolization;
arsenic trioxide;
primary liver cancer;
observation of curative effect
- From:
The Journal of Practical Medicine
2018;34(2):251-253
- CountryChina
- Language:Chinese
-
Abstract:
Objective This paper aims to observe and analyze the effect of hepatic arterial chemoemboliza-tion combined with arsenic trioxide injection in the patients with primary liver cancer.Methods This study includ-ed Ninety patients with primary liver cancer who were treated in our hospital from January 2013 to June 2016.The patients were divided into the study group and control group and the two groups were given different treatment proto-cols. The patients in the control group were treated with hepatic arterial chemoembolization and the patients in the study group were treated with arsenic trioxide injection.On the basis of the treatment effect was observed and com-pared. Results There was no significant difference between the two groups in recent curative effect(P > 0.05);the study group had higher one year survival rate than the control group(P<0.05).There was no significant differ-ence between the two groups in adverse reactions(P>0.05);the study group was superior to the control group in terms of improvement of quality of life(P < 0.05). Conclusions Hepatic arterial chemoembolization combined with arsenic trioxide injection can improve one year survival rate of primary liver cancer patients,and provide good long-term survival rate without obvious adverse reactions,and improve quality of life of patients.
